266 related articles for article (PubMed ID: 9360513)
1. Urinary follicle-stimulating hormone for normogonadotropic clomiphene-resistant anovulatory infertility: prospective, randomized comparison between low dose step-up and step-down dose regimens.
van Santbrink EJ; Fauser BC
J Clin Endocrinol Metab; 1997 Nov; 82(11):3597-602. PubMed ID: 9360513
[TBL] [Abstract][Full Text] [Related]
2. Ovulation induction in clomiphene-resistant anovulatory women: differential follicular response to purified urinary follicle-stimulating hormone (FSH) versus purified urinary FSH and luteinizing hormone.
Hoffman DI; Lobo RA; Campeau JD; Tsai HM; Holmberg EA; Ono T; Frederick JJ; Platt LD; diZerega GS
J Clin Endocrinol Metab; 1985 May; 60(5):922-7. PubMed ID: 3920235
[TBL] [Abstract][Full Text] [Related]
3. Initial estradiol response predicts outcome of exogenous gonadotropins using a step-down dose regimen for induction of ovulation in polycystic ovary syndrome.
Schoot DC; Hop WC; de Jong FH; van Dessel TJ; Fauser BC
Fertil Steril; 1995 Dec; 64(6):1081-7. PubMed ID: 7589656
[TBL] [Abstract][Full Text] [Related]
4. [Chronic low dose follicle stimulating hormone step-up regimen in the treatment of polycystic ovary syndrome related anovulatory infertility with clomiphene resistance].
Chen W; Zhang Y; Dai Q
Zhonghua Fu Chan Ke Za Zhi; 2000 Oct; 35(10):588-90. PubMed ID: 11372406
[TBL] [Abstract][Full Text] [Related]
5. Urinary follicle-stimulating hormone (FSH) versus recombinant FSH in clomiphene citrate-resistant, normogonadotropic,chronic anovulation: a prospective randomized study.
Yarali H; Bukulmez O; Gurgan T
Fertil Steril; 1999 Aug; 72(2):276-81. PubMed ID: 10438995
[TBL] [Abstract][Full Text] [Related]
6. An effective alternative to only gonadotrophin for controlled ovarian stimulation in unexplained infertility patients undergoing intra-uterine insemination: a clinical trial.
Chaudhury K; Chaudhury S; Khastgir G; Purakaystha S
J Indian Med Assoc; 2013 Sep; 111(9):589-92, 594. PubMed ID: 24968520
[TBL] [Abstract][Full Text] [Related]
7. Sequential step-up and step-down dose regimen: an alternative method for ovulation induction with follicle-stimulating hormone in polycystic ovarian syndrome.
Hugues JN; Cédrin-Durnerin I; Avril C; Bulwa S; Hervé F; Uzan M
Hum Reprod; 1996 Dec; 11(12):2581-4. PubMed ID: 9021354
[TBL] [Abstract][Full Text] [Related]
8. The step-down principle in gonadotrophin treatment and the role of GnRH analogues.
Fauser BC; Donderwinkel P; Schoot DC
Baillieres Clin Obstet Gynaecol; 1993 Jun; 7(2):309-30. PubMed ID: 8358893
[TBL] [Abstract][Full Text] [Related]
9. Follicular development and hormone concentrations following recombinant FSH administration for anovulation associated with polycystic ovarian syndrome: prospective, randomized comparison between low-dose step-up and modified step-down regimens.
Balasch J; Fábregues F; Creus M; Puerto B; Peñarrubia J; Vanrell JA
Hum Reprod; 2001 Apr; 16(4):652-6. PubMed ID: 11278212
[TBL] [Abstract][Full Text] [Related]
10. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
Calaf Alsina J; Ruiz Balda JA; Romeu Sarrió A; Caballero Fernández V; Cano Trigo I; Gómez Parga JL; González Batres C; Rodríguez Escudero FJ
BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878
[TBL] [Abstract][Full Text] [Related]
11. Recombinant follicle-stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective, multicenter, assessor-blind, randomized, clinical trial. European Puregon Collaborative Anovulation Study Group.
Coelingh Bennink HJ; Fauser BC; Out HJ
Fertil Steril; 1998 Jan; 69(1):19-25. PubMed ID: 9457926
[TBL] [Abstract][Full Text] [Related]
12. Factors related to successful ovulation induction in patients with WHO group II anovulatory infertility.
Howles CM; Alam V; Tredway D; Homburg R; Warne DW
Reprod Biomed Online; 2010 Feb; 20(2):182-90. PubMed ID: 20113956
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamics of a single low dose of long-acting recombinant follicle-stimulating hormone (FSH-carboxy terminal peptide, corifollitropin alfa) in women with World Health Organization group II anovulatory infertility.
Balen AH; Mulders AG; Fauser BC; Schoot BC; Renier MA; Devroey P; Struijs MJ; Mannaerts BM
J Clin Endocrinol Metab; 2004 Dec; 89(12):6297-304. PubMed ID: 15579793
[TBL] [Abstract][Full Text] [Related]
14. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
[TBL] [Abstract][Full Text] [Related]
15. Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol.
Griesinger G; Schultze-Mosgau A; Dafopoulos K; Schroeder A; Schroer A; von Otte S; Hornung D; Diedrich K; Felberbaum R
Hum Reprod; 2005 May; 20(5):1200-6. PubMed ID: 15665010
[TBL] [Abstract][Full Text] [Related]
16. Successful induction of ovulation and conception with pulsatile intravenous administration of human menopausal gonadotropins in anovulatory infertile women resistant to clomiphene and pulsatile gonadotropin-releasing hormone therapy.
Ho Yuen B; Pride SM; Sime MO
Am J Obstet Gynecol; 1984 Mar; 148(5):508-12. PubMed ID: 6422760
[TBL] [Abstract][Full Text] [Related]
17. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
[TBL] [Abstract][Full Text] [Related]
18. Prediction of the individual follicle-stimulating hormone threshold for gonadotropin induction of ovulation in normogonadotropic anovulatory infertility: an approach to increase safety and efficiency.
Imani B; Eijkemans MJ; Faessen GH; Bouchard P; Giudice LC; Fauser BC
Fertil Steril; 2002 Jan; 77(1):83-90. PubMed ID: 11779595
[TBL] [Abstract][Full Text] [Related]
19. FSH response-dose can be predicted in ovulation induction for normogonadotropic anovulatory infertility.
van Santbrink EJ; Eijkemans MJ; Macklon NS; Fauser BC
Eur J Endocrinol; 2002 Aug; 147(2):223-6. PubMed ID: 12153744
[TBL] [Abstract][Full Text] [Related]
20. A randomized controlled dose-response pilot study of addition of hCG to recombinant FSH during controlled ovarian stimulation for in vitro fertilization.
Thuesen LL; Loft A; Egeberg AN; Smitz J; Petersen JH; Andersen AN
Hum Reprod; 2012 Oct; 27(10):3074-84. PubMed ID: 22791754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
